Galmed Pharmaceuticals (GLMD) Short Interest Ratio & Short Volume $1.36 -0.01 (-0.36%) As of 01:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Galmed Pharmaceuticals Short Interest DataGalmed Pharmaceuticals (GLMD) has a short interest of 416,100 shares, representing 18.74% of the float (the number of shares available for trading by the public). This marks a 331.64% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 1.29 million shares to cover all short positions.Current Short Interest416,100 sharesPrevious Short Interest96,400 sharesChange Vs. Previous Month+331.64%Dollar Volume Sold Short$540,930.00Short Interest Ratio0.2 Days to CoverLast Record DateApril 30, 2025Outstanding Shares1,654,000 sharesFloat Size2,220,000 sharesShort Percent of Float18.74%Today's Trading Volume91,076 sharesAverage Trading Volume1,285,546 sharesToday's Volume Vs. Average7% Short Selling Galmed Pharmaceuticals? Sign up to receive the latest short interest report for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGLMD Short Interest Over TimeGLMD Days to Cover Over TimeGLMD Percentage of Float Shorted Over Time Galmed Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025416,100 shares $540,930.00 +331.6%18.7%0.2 $1.30 4/15/202596,400 shares $135,924.00 +41.4%4.3%0.1 $1.41 3/31/202568,200 shares $98,208.00 +40.6%3.1%0.1 $1.44 3/15/202548,500 shares $83,754.65 +889.8%3.0%0.1 $1.73 2/28/20254,900 shares $10,652.60 +19.5%0.3%0.1 $2.17 2/15/20254,100 shares $10,496.00 -39.7%0.3%0.1 $2.56 1/31/20256,800 shares $19,074.00 +13.3%0.4%0.2 $2.81 1/15/20256,000 shares $16,740.00 -41.2%0.4%0.1 $2.79 12/31/202410,200 shares $32,538.00 -31.1%0.6%0.1 $3.19 12/15/202414,800 shares $43,956.00 -35.1%0.9%0.1 $2.97 Get the Latest News and Ratings for GLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/30/202422,800 shares $65,208.00 +31.0%1.4%0 $2.86 11/15/202417,400 shares $50,982.00 -62.1%1.1%0 $2.93 10/31/202445,900 shares $153,306.00 +73.9%3.1%0 $3.34 10/15/202426,400 shares $103,488.00 -22.8%1.8%0 $3.92 9/30/202434,200 shares $234,612.00 +9.6%2.3%0 $6.86 9/15/202431,200 shares $128,232.00 -23.2%5.0%0 $4.11 8/31/202440,600 shares $137,228.00 +235.5%6.6%0.8 $3.38 8/15/202412,100 shares $3,628.79 +17.5%0.2%0 $0.30 7/31/202410,300 shares $3,166.22 +14.4%0.2%0.2 $0.31 7/15/20249,000 shares $2,723.40 +1,185.7%0.2%0.2 $0.30 6/30/2024700 shares $192.50 -94.9%0.0%0 $0.28 6/15/202413,700 shares $4,557.99 -42.4%0.2%0.1 $0.33 5/31/202423,800 shares $8,808.38 -67.3%0.4%0.1 $0.37 5/15/202472,800 shares $27,918.80 -13.1%1.3%0.4 $0.38 4/30/202483,800 shares $29,497.60 +6.1%1.5%0.4 $0.35 4/15/202479,000 shares $30,012.10 +101.5%2.2%0.4 $0.38 3/31/202439,200 shares $13,574.96 +532.3%1.1%0.2 $0.35 3/15/20246,200 shares $1,891.62 -84.9%0.2%0 $0.31 2/29/202441,000 shares $16,322.10 -46.1%1.2%0.4 $0.40 2/15/202476,000 shares $28,887.60 +560.9%2.1%0.6 $0.38 1/31/202411,500 shares $4,311.35 -79.1%0.3%0.1 $0.37 1/15/202455,100 shares $25,015.40 -9.7%1.5%0.3 $0.45 12/31/202361,000 shares $27,755.00 +65.3%1.7%0.4 $0.46 12/15/202336,900 shares $13,165.92 -56.9%1.0%0.2 $0.36 11/30/202385,700 shares $30,423.50 +564.3%2.4%0.4 $0.36 11/15/202312,900 shares $5,160.00 +17.3%0.4%0.1 $0.40 10/31/202311,000 shares $4,180.00 -1.8%0.3%0.2 $0.38 10/15/202311,200 shares $4,592.00 +75.0%0.3%0.1 $0.41 9/30/20236,400 shares $3,968.00 +88.2%0.2%0 $0.62 9/15/20233,400 shares $2,515.66 -52.8%0.1%0 $0.74Watch This Robotics Demo Before July 23rd (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… 8/31/20237,200 shares $5,824.80 -32.7%0.2%0 $0.81 8/15/202310,700 shares $8,669.14 -61.1%0.3%0 $0.81 7/31/202327,500 shares $31,625.00 -92.3%1.5%0.1 $1.15 7/15/2023357,100 shares $517,795.00 +2,668.2%20.1%1.3 $1.45 6/30/202312,900 shares $37,539.00 -6.5%0.9%0.1 $2.91 6/15/202313,800 shares $51,474.00 -14.3%1.0%0.5 $3.73 5/31/202316,100 shares $74,221.00 -18.7%1.1%0.7 $4.61 5/15/202319,800 shares $0.00 +1,700.0%1.4%0.9 $0.00 4/30/202317,200 shares $5,332.00 -6.5%0.1%0.1 $0.31 4/15/202318,400 shares $5,704.00 -30.3%0.1%0.3 $0.31 3/31/202326,400 shares $11,259.60 -28.5%0.1%0.3 $0.43 3/15/202336,900 shares $17,239.68 +58.4%0.2%0.3 $0.47 2/28/202323,300 shares $11,184.00 -32.1%0.1%0.2 $0.48 2/15/202334,300 shares $20,923.00 +106.6%0.2%0.2 $0.61 1/31/202316,600 shares $10,974.26 -88.4%0.1%0.1 $0.66 1/15/2023143,500 shares $115,058.30 -2.3%0.7%1.1 $0.80 12/30/2022146,900 shares $73,450.00 +57.3%0.7%1.3 $0.50 12/15/202293,400 shares $27,086.00 +233.6%0.4%1.1 $0.29 11/30/202228,000 shares $8,173.20 +53.0%0.1%0.8 $0.29 11/15/202218,300 shares $6,101.22 -45.9%0.1%0.4 $0.33 10/31/202233,800 shares $12,847.38 +80.8%0.2%0.6 $0.38 10/15/202218,700 shares $7,264.95 +22.2%0.1%0.3 $0.39 9/30/202215,300 shares $4,759.59 -57.5%0.1%0.2 $0.31 9/15/202236,000 shares $16,563.60 -35.5%0.2%0.4 $0.46 8/31/202255,800 shares $25,896.78 +234.1%0.3%0.5 $0.46 8/15/202216,700 shares $7,424.82 -34.0%0.1%0.2 $0.44 7/31/202225,300 shares $12,703.13 -29.3%0.1%0.2 $0.50 7/15/202235,800 shares $21,651.84 -66.4%0.2%0.3 $0.60 6/30/2022106,600 shares $69,290.00 -0.7%0.5%0.9 $0.65 6/15/2022107,300 shares $48,285.00 +364.5%0.5%1.1 $0.45 5/31/202223,100 shares $11,817.96 -0.4%0.1%0.2 $0.51 5/15/202223,200 shares $14,105.60 -27.3%0.1%0.3 $0.61 4/30/202231,900 shares $52,954.00 -37.6%0.2%0.4 $1.66 4/15/202251,100 shares $83,293.00 -6.2%0.2%0.9 $1.63 3/31/202254,500 shares $86,655.00 -47.3%0.3%0.5 $1.59 3/15/2022103,500 shares $127,305.00 -36.0%0.5%0.8 $1.23 2/28/2022161,700 shares $232,848.00 -30.9%0.8%1.2 $1.44 2/15/2022234,100 shares $374,560.00 -17.9%1.1%1.7 $1.60 1/31/2022285,200 shares $462,024.00 +21.7%1.3%1.8 $1.62 1/15/2022234,300 shares $374,880.00 +20.5%N/A1.3 $1.60 12/31/2021194,400 shares $353,808.00 -36.4%1.0%1.1 $1.82 12/15/2021305,500 shares $653,770.00 +7.0%1.5%2.5 $2.14 11/30/2021285,600 shares $719,712.00 -15.6%1.4%2.4 $2.52 11/15/2021338,500 shares $1.01 million +24.6%1.7%2.7 $2.98 10/29/2021271,700 shares $671,099.00 -16.9%1.3%2.2 $2.47 10/15/2021326,900 shares $898,975.00 +2.7%1.6%1.4 $2.75 9/30/2021318,300 shares $888,057.00 -17.0%1.6%1.4 $2.79 9/15/2021383,700 shares $1.12 million -10.8%1.9%1.6 $2.91 8/31/2021430,100 shares $1.41 million -8.0%2.1%1.7 $3.27 8/13/2021467,500 shares $1.38 million -28.5%2.3%1.4 $2.95Watch This Robotics Demo Before July 23rd (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… 7/30/2021654,000 shares $1.63 million +0.8%3.3%1.8 $2.49 7/15/2021648,700 shares $1.69 million -0.6%3.2%2.4 $2.61 6/30/2021652,500 shares $1.98 million +23.6%3.3%2.3 $3.04 6/15/2021527,900 shares $1.68 million +97.9%2.6%1.8 $3.18 5/28/2021266,800 shares $693,680.00 -1.4%1.3%0.8 $2.60 5/14/2021270,700 shares $606,368.00 -16.4%1.4%1 $2.24 4/30/2021323,900 shares $1.09 million -2.4%1.6%0.8 $3.37 4/15/2021331,700 shares $1.09 million +15.1%1.7%0.8 $3.30 3/31/2021288,300 shares $960,039.00 +30.2%1.5%0.7 $3.33 3/15/2021221,500 shares $775,250.00 +14.8%1.1%0.5 $3.50 2/26/2021192,900 shares $792,819.00 +389.6%1.1%0.5 $4.11 2/12/202139,400 shares $212,760.00 +4.2%0.2%0.1 $5.40 1/29/202137,800 shares $142,695.00 +49.4%0.2%0.2 $3.78 1/15/202125,300 shares $88,044.00 -22.6%0.2%0.2 $3.48 12/31/202032,700 shares $106,929.00 +26.3%0.2%0.3 $3.27 12/15/202025,900 shares $94,794.00 -29.0%0.2%0.3 $3.66 11/30/202036,500 shares $152,205.00 +55.3%0.2%0.5 $4.17 11/15/202023,500 shares $79,665.00 +109.8%0.2%0.3 $3.39 10/30/202011,200 shares $34,384.00 -49.6%0.1%0.2 $3.07 10/15/202022,200 shares $74,370.00 -53.0%0.1%0.3 $3.35 9/30/202047,200 shares $166,616.00 -28.9%0.3%0.5 $3.53 9/15/202066,400 shares $278,880.00 -65.2%0.4%0.8 $4.20 8/31/2020191,000 shares $932,080.00 -56.7%1.2%2.3 $4.88 8/14/2020441,500 shares $2.09 million -3.0%2.8%5.1 $4.74 7/31/2020455,100 shares $2.21 million -2.5%2.9%4.6 $4.85 7/15/2020466,700 shares $2.20 million +0.3%3.2%5.2 $4.72 6/30/2020465,500 shares $2.25 million +23.8%3.2%5.8 $4.84 6/15/2020376,000 shares $1.85 million +1.1%2.5%4.5 $4.92 5/29/2020372,000 shares $1.77 million -4.6%2.5%4 $4.75 GLMD Short Interest - Frequently Asked Questions What is Galmed Pharmaceuticals' current short interest? Short interest is the volume of Galmed Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 416,100 shares of GLMD short. 18.74% of Galmed Pharmaceuticals' shares are currently sold short. Learn More on Galmed Pharmaceuticals' current short interest. What is a good short interest percentage for Galmed Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.74% of Galmed Pharmaceuticals' floating shares are currently sold short. Is Galmed Pharmaceuticals' short interest increasing or decreasing? Galmed Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 416,100 shares, an increase of 331.6% from the previous total of 96,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Galmed Pharmaceuticals' float size? Galmed Pharmaceuticals currently has issued a total of 1,654,000 shares. Some of Galmed Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Galmed Pharmaceuticals currently has a public float of 2,220,000 shares. How does Galmed Pharmaceuticals' short interest compare to its competitors? 18.74% of Galmed Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Galmed Pharmaceuticals: TransCode Therapeutics, Inc. (5.43%), Addex Therapeutics Ltd (0.35%), Cardio Diagnostics Holdings, Inc. (2.72%), BioXcel Therapeutics, Inc. (1.93%), Carisma Therapeutics, Inc. (1.38%), Portage Biotech Inc. (69.97%), Brainstorm Cell Therapeutics Inc. (5.17%), Aytu BioPharma, Inc. (2.27%), Turnstone Biologics Corp. (2.03%), Citius Pharmaceuticals, Inc. (7.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Galmed Pharmaceuticals stock? Short selling GLMD is an investing strategy that aims to generate trading profit from Galmed Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Galmed Pharmaceuticals? A short squeeze for Galmed Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GLMD, which in turn drives the price of the stock up even further. How often is Galmed Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLMD, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies TransCode Therapeutics Short Interest Data Addex Therapeutics Short Interest Data Cardio Diagnostics Short Interest Data BioXcel Therapeutics Short Interest Data Carisma Therapeutics Short Interest Data Portage Biotech Short Interest Data Brainstorm Cell Therapeutics Short Interest Data Aytu BioPharma Short Interest Data Turnstone Biologics Short Interest Data Citius Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GLMD) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galmed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GLMD Stock Free GLMD Stock Alerts